A natural polysaccharide hydrogel loaded with platelet-rich plasma, its preparation method and application
By using a natural polysaccharide hydrogel loaded with platelet-rich plasma and utilizing a dynamic cross-linking network and growth factors, the low self-healing rate of tympanic membrane perforation and the shortcomings of traditional repair materials have been solved, achieving simple and effective tympanic membrane repair and hearing recovery.
Patent Information
- Application Number
- CN202411990545.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-31
- Publication Date
- 2026-06-30
AI Technical Summary
In existing technologies, the self-healing rate of tympanic membrane perforation is low, and traditional repair materials have problems such as insufficient autologous tissue, complicated surgery, easy deformation and immune rejection, and are difficult to operate effectively in the small field of vision of the ear.
A hydrogel with good injectability was prepared by using natural polysaccharide hydrogel loaded with platelet-rich plasma and forming a dynamic cross-linking network between chitosan derivatives and aldehyde-modified natural polysaccharides. This hydrogel combines with growth factors in platelet-rich plasma to promote healing.
It enables simple operation within a small field of vision in the ear, promotes tympanic membrane healing, reduces the risk of inflammation, improves hearing recovery, and avoids immune rejection.
Smart Images

Figure CN122297781A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biomedical polymer materials, specifically relating to a natural polysaccharide hydrogel loaded with platelet-rich plasma, its preparation method, and its application. Background Technology
[0002] Tympanic membrane perforation is a common ENT condition, with common causes including foreign bodies in the ear canal, acute and chronic otitis media, middle or inner ear tumors, iatrogenic injury, and barotrauma. Clinically, it often manifests as ear pain, tinnitus, varying degrees of hearing loss, and recurrent middle ear infections. Most tympanic membrane perforations heal spontaneously within 7 to 10 days; these rapidly healing perforations are classified as acute tympanic membrane perforations. Up to 90% of acute tympanic membrane perforations heal spontaneously without intervention, but about 10% become chronic. Chronic tympanic membrane perforations lead to hearing loss in over 50% of cases and are associated with impaired language and cognitive development. Tympanic membrane perforation and associated hearing loss reduce the efficiency and frequency range of sound propagation, and are a global health problem.
[0003] Tympanoplasty is usually required for tympanic membrane perforations that have not healed within 1-3 months. Tympanoplasty is considered the most effective treatment for tympanic membrane perforations. Clinically, the surgery typically uses autologous tissue grafts such as temporalis fascia, tragus cartilage, perichondrium, and fat to repair the perforated tympanic membrane. This method has advantages such as low rejection rate. However, it also has drawbacks, including the ease of graft deformation, long and complex surgery time, insufficient autologous material for secondary repairs, and the need for additional incisions due to tissue transplantation. Furthermore, it relies heavily on "repairing trauma with trauma," increasing the morbidity rate at the donor site. Additionally, the repaired tympanic membrane often fails to reach the normal position and physiological state due to the limited field of vision in the ear, resulting in hearing recovery not meeting expectations.
[0004] Developing novel tympanic membrane repair materials based on bioengineering strategies provides a new approach to treating tympanic membrane perforation. This involves developing new materials suitable for small areas of the ear and promoting tympanic membrane healing, overcoming the shortcomings of traditional treatment methods. These materials not only solve the inconvenience of operation in small areas of the ear but also promote cell growth and possess appropriate adhesion to ensure that they do not fall off after reaching the designated location.
[0005] Platelet-rich plasma (PRP) is rich in amino acids and various growth factors, which can promote cell growth and inhibit inflammation. However, PRP-based hydrogels have low modulus and poor self-support, making them unsuitable for direct application. Developing PRP-based hydrogels holds promise for their potential role in the treatment of tympanic membrane perforation. Summary of the Invention
[0006] The purpose of this section is to outline some aspects of embodiments of the present invention and to briefly describe some preferred embodiments. Simplifications or omissions may be made in this section, as well as in the abstract and title of this application, to avoid obscuring the purpose of these documents; however, such simplifications or omissions should not be construed as limiting the scope of the invention.
[0007] In view of the problems existing in the above and / or prior art, the present invention is proposed.
[0008] Therefore, the purpose of this invention is to overcome the shortcomings of the prior art and provide a natural polysaccharide hydrogel loaded with platelet-rich plasma.
[0009] To solve the above-mentioned technical problems, the present invention provides the following technical solution: a natural polysaccharide hydrogel loaded with platelet-rich plasma, comprising,
[0010] Chitosan derivatives, aldehyde-modified natural polysaccharides, and platelet-rich plasma;
[0011] The hydrogel network is a dynamic cross-linked network, comprising a Schiff base-based dynamic cross-linked network formed by the amino and aldehyde-modified carboxyl groups of chitosan derivatives and platelet-rich plasma.
[0012] As a preferred embodiment of the natural polysaccharide hydrogel described in this invention, the chitosan derivative is one or more of carboxymethyl chitosan and quaternary ammonium chitosan.
[0013] The aldehyde-modified natural polysaccharide is one or more of aldehyde-modified hyaluronic acid and aldehyde-modified chondroitin sulfate.
[0014] Another object of the present invention is to overcome the shortcomings of the prior art and provide a method for preparing natural polysaccharide hydrogels, characterized in that: it includes,
[0015] A mixture containing chitosan derivatives, aldehyde-modified natural polysaccharides, and platelet-rich plasma was reacted at room temperature to obtain the platelet-loaded natural polysaccharide hydrogel.
[0016] As a preferred embodiment of the preparation method described in this invention, the method includes dissolving a chitosan derivative in platelet-rich plasma to obtain solution A;
[0017] Prepare solution B containing aldehyde-modified natural polysaccharides;
[0018] Solution A and solution B are mixed and reacted at room temperature to obtain the natural polysaccharide hydrogel loaded with platelet-rich plasma.
[0019] In a preferred embodiment of the preparation method described in this invention, the concentration of the chitosan derivative in solution A is 3-5 wt%.
[0020] In solution B, the concentration of aldehyde-modified natural polysaccharide is 2-6 wt%.
[0021] The volume ratio of solution A to solution B is 1 to 16:4.
[0022] In a preferred embodiment of the preparation method described in this invention, the solvent used in solution B is an aqueous sodium chloride solution;
[0023] The concentration of the sodium chloride aqueous solution is 0.9–4 wt%.
[0024] In a preferred embodiment of the preparation method described in this invention, the concentration of the chitosan derivative is 3 wt%, 3.5 wt%, 4 wt%, 4.5 wt%, or 5 wt%.
[0025] In a preferred embodiment of the preparation method described in this invention, the concentration of the aldehyde-modified natural polysaccharide is 2wt%, 2.5wt%, 3wt%, 3.5wt%, 4wt%, 4.5wt%, 5wt%, 5.5wt%, or 6wt%.
[0026] Another objective of this invention is to overcome the shortcomings of the prior art and provide an application of natural polysaccharide hydrogel as a tympanic membrane repair material.
[0027] Beneficial effects of this invention:
[0028] (1) The natural polysaccharide hydrogel loaded with platelet-rich plasma provided by the present invention has a dynamic cross-linking network, good injectability, and exhibits a flowing state when subjected to shear force. After the shear force is removed, it can instantly gel and form a shape. It is simple to operate, has controllable strength, and is suitable for operation in small fields of vision in the ear.
[0029] (2) The raw materials used in this invention are chitosan derivatives and aldehyde-modified natural polysaccharides, which are both natural polysaccharides with good biocompatibility. Aldehyde-modified natural polysaccharides can promote tympanic membrane healing. Platelet-rich plasma is extracted from autologous blood, which avoids immune rejection and reduces the probability of infection. It also contains a variety of high-concentration growth factors that promote cell proliferation and differentiation, which can promote cell growth and inhibit inflammation. Attached Figure Description
[0030] To more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings used in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort. Wherein:
[0031] Figure 1This describes the adhesion properties of the hydrogel obtained in Example 1 of the present invention on the skin.
[0032] Figure 2 The rheological properties of the hydrogel obtained in Example 1 of the present invention are as follows: (a) Curves showing the changes in storage modulus G' and loss modulus G” over time (the inset shows the observation of the gelation process by inverting the bottle).
[0033] Figure 3 The rheological properties of the hydrogel obtained in Example 1 of the present invention are as follows: (a) Curves showing the changes in storage modulus G' and loss modulus G” with shear strain.
[0034] Figure 4 The rheological properties of the hydrogel obtained in Example 2 of this invention are shown in the curves of the changes in storage modulus G' and loss modulus G” under alternating time scans of 1% and 500% strain.
[0035] Figure 5 This is a diagram illustrating the healing effect of Embodiment 1 of the present invention in acute perforation. Detailed Implementation
[0036] To make the above-mentioned objects, features and advantages of the present invention more apparent and understandable, the specific embodiments of the present invention will be described in detail below with reference to the examples in the specification.
[0037] Many specific details are set forth in the following description in order to provide a full understanding of the invention. However, the invention may also be practiced in other ways different from those described herein, and those skilled in the art can make similar extensions without departing from the spirit of the invention. Therefore, the invention is not limited to the specific embodiments disclosed below.
[0038] Secondly, the term "one embodiment" or "embodiment" as used herein refers to a specific feature, structure, or characteristic that may be included in at least one implementation of the present invention. The phrase "in one embodiment" appearing in different places in this specification does not necessarily refer to the same embodiment, nor is it a single or selective embodiment that is mutually exclusive with other embodiments.
[0039] Unless otherwise specified, all raw materials used in the embodiments of this application were purchased through commercial channels.
[0040] In this application, the preparation of aldehyde-modified natural polysaccharides is as follows: a certain amount of natural polysaccharide is weighed, poured into deionized water, and stirred at room temperature until completely dissolved to obtain a natural polysaccharide solution with a concentration of 1% (wt / v).
[0041] Subsequently, sodium periodate was added at a ratio of 0.2-0.4g sodium periodate per gram of natural polysaccharide, and the reaction was carried out in the dark for 2-4 hours.
[0042] Then, add an equal volume of ethylene glycol and continue stirring for 1-2 hours;
[0043] Finally, the above solution was placed in a dialysis bag and dialyzed for 3-5 days. It was then freeze-dried at -65°C to obtain aldehyde-modified natural polysaccharides, which were then stored at -18°C for later use.
[0044] Example 1
[0045] (1) Preparation of aldehyde-modified natural polysaccharides: Weigh 2g of sodium hyaluronate, pour it into 200mL of deionized water, stir at room temperature until completely dissolved, and obtain a 1% (wt / v) sodium hyaluronate aqueous solution.
[0046] (2) Then, sodium periodate was added at a ratio of 0.4 g sodium periodate per gram of sodium hyaluronate, and the reaction was carried out in the dark for 2 hours.
[0047] (3) Then, add 0.4g of ethylene glycol and continue stirring for 1 hour;
[0048] (4) Finally, the above solution was placed in a dialysis bag and dialyzed for 5 days. It was then freeze-dried at -65°C to obtain aldehyde-modified hyaluronic acid, which was stored at -18°C for later use.
[0049] (5) Hydrogel preparation: Weigh a certain amount of carboxymethyl chitosan (substitution degree ≥80%), dissolve it in platelet-rich plasma, and obtain a chitosan derivative solution with a concentration of 4% (wt / v);
[0050] Subsequently, a certain amount of aldehyde-modified sodium hyaluronate was weighed and dissolved in a 0.9 wt% sodium chloride solution, wherein the concentration of aldehyde-modified hyaluronic acid was 6% (wt / v);
[0051] The two solutions were measured separately and mixed at a volume ratio of 1:4 to obtain an injectable hydrogel material. This is designated as Sample 1.
[0052] The prepared hydrogel was first applied to the finger, then rotated 180°, from... Figure 1 The hydrogel exhibits good adhesion, remaining firmly attached to the skin even after being flipped. Furthermore, when the prepared hydrogel is first applied to a finger, then the finger is bent, and finally returned to its original position, it... Figure 1 In this process, we can observe that the hydrogel adheres firmly to the skin without falling off or creating gaps, demonstrating not only good adhesion but also good conformal ability.
[0053] Example 2
[0054] (1) The preparation method of aldehyde-modified natural polysaccharide is the same as in Example 1, except that it is added at a ratio of 0.2 g sodium periodate per gram of sodium hyaluronate, and the reaction is carried out in the dark for 4 hours. The amount of ethylene glycol added is 0.2 g, the stirring time is 2 hours, and the dialysis is carried out for 5 days.
[0055] (2) Hydrogel preparation: Weigh a certain amount of quaternary ammonium salt chitosan and dissolve it in platelet-rich plasma to obtain a chitosan derivative solution with a concentration of 3% (wt / v);
[0056] Subsequently, a certain amount of aldehyde-modified hyaluronic acid was weighed and dissolved in a 1.5 wt% sodium chloride solution, wherein the concentration of sodium aldehyde-modified hyaluronic acid was 2% (wt / v);
[0057] The two solutions were measured separately and mixed at a volume ratio of 16:4 to obtain an injectable hydrogel material. This is designated as Sample 2.
[0058] Example 3
[0059] (1) The preparation method of aldehyde-modified natural polysaccharide is the same as in Example 1, except that chondroitin sulfate is used as the natural polysaccharide, and it is added at a ratio of 0.3 g sodium periodate per gram of chondroitin sulfate. The reaction is carried out in the dark for 3 hours. The amount of ethylene glycol added is 0.3 g, the stirring time is 2 hours, and the reaction is dialyzed for 4 days.
[0060] (2) Hydrogel preparation: Weigh a certain amount of quaternary ammonium salt chitosan and dissolve it in platelet-rich plasma to obtain a 5% (wt / v) chitosan derivative solution.
[0061] Subsequently, a certain amount of aldehyde-modified chondroitin sulfate was weighed and dissolved in a 3 wt% sodium chloride solution, wherein the concentration of aldehyde-modified sodium hyaluronate was 4% (wt / v).
[0062] The two solutions were measured separately and mixed at a volume ratio of 12:4 to obtain an injectable hydrogel material, which was designated as sample 3.
[0063] Example 4
[0064] (1) The preparation method of aldehyde-modified natural polysaccharide is the same as in Example 1, except that the natural polysaccharide is chondroitin sulfate, which is added at a ratio of 0.3 g sodium periodate per gram of chondroitin sulfate, and the reaction is carried out in the dark for 3 hours; the amount of ethylene glycol added is 0.3 g, the stirring time is 1 hour, and the dialysis is carried out for 3 days.
[0065] (2) Hydrogel preparation: Weigh a certain amount of carboxymethyl chitosan and dissolve it in platelet-rich plasma to obtain a chitosan derivative solution with a concentration of 3.5% (wt / v);
[0066] Subsequently, a certain amount of aldehyde-modified chondroitin sulfate was weighed and dissolved in a 4 wt% sodium chloride solution, wherein the concentration of aldehyde-modified sodium hyaluronate was 5% (wt / v).
[0067] The two solutions were measured separately and mixed at a volume ratio of 8:4 to obtain an injectable hydrogel material. This is designated as Sample 4.
[0068] Comparative Example 1
[0069] When the 0.9 wt% sodium chloride solution in Example 1 was replaced with a 0.1 mol / L calcium chloride solution or a PBS solution, a gel could not be formed after mixing.
[0070] Comparative Example 2
[0071] The steps are the same as in Example 1, except that platelet-rich plasma is not added. Instead, the platelet-rich plasma in Example 1 is replaced with 0.9 wt% sodium chloride solution to obtain an injectable hydrogel.
[0072] The energy storage modulus and loss modulus of the sample were measured by a rheometer and were comparable to those of Example 1, with no significant difference.
[0073] Comparative Example 3
[0074] A certain amount of platelet-rich plasma was measured and added to an activation solution (2000 IU thrombin + 4 mL CaCl2 (2 wt%)) to obtain pure platelet-rich plasma hydrogel.
[0075] The amount of activation solution added is related to platelet-rich plasma; 80 microliters of activation solution are added to 1 mL of platelet-rich plasma.
[0076] Rheometer tests showed that its energy storage modulus and loss modulus decreased significantly compared to Example 1, with the energy storage modulus being only 23.5 Pa.
[0077] Comparative Example 4
[0078] The 4% (wt / v) chitosan derivative solution in Example 1 was replaced with a platelet-rich plasma solution; after mixing, it was found that the gelation time was too long, 15 minutes.
[0079] The obtained samples were subjected to performance testing:
[0080] The rheological properties of the obtained hydrogel material samples were tested using a DHR-2 rheometer from the American TA Instruments. The results showed that the platelet-loaded plasma-containing natural polysaccharide hydrogel material prepared in this application has good injectability.
[0081] The following examples are typically used to illustrate the situation: Sample 1 obtained in Example 1 and Sample 2 obtained in Example 2.
[0082] Figure 2 The storage modulus G' and loss modulus G” of sample 1 vary with time. Figure 2 It can be seen that at the initial moment of the test, the storage modulus G' was already greater than the loss modulus G", and it had already exhibited a gel state. This indicates that the hydrogel can gel rapidly, even before the test can proceed. Combined with the observation using the inverted bottle method, it can be seen that the gel can gel within 5 seconds.
[0083] Figure 3 The figures show the storage modulus G' and loss modulus G” of sample 1 as a function of shear strain. Figure 3 It can be seen that under low shear strain, the storage modulus G' of this hydrogel material is greater than the loss modulus G”, exhibiting a typical gel state and not flowing; when the shear strain exceeds 135%, its loss modulus G” is greater than the storage modulus G', exhibiting a sol state, having fluidity, and demonstrating good injectability.
[0084] Figure 4 The curves show the changes in storage modulus G' and loss modulus G” of sample 2 under alternating time scans of 1% and 500% strain. Figure 4 It can be observed that when the hydrogel material is scanned at alternating times of 1% strain and 500% strain, at 1% strain, its storage modulus G' is greater than its loss modulus G”, exhibiting a gel state. When 500% strain is applied, its loss modulus G” is greater than its storage modulus G', exhibiting a sol state.
[0085] When the shear force is removed, the hydrogel reverts to its gel state; such a gel can repeatedly undergo shear thinning and repeatedly transition between gel and sol states. This phenomenon is related to the network structure of the hydrogel, where dynamic covalent bonds are constructed between the amino groups on chitosan derivatives and platelet-rich plasma and the aldehyde groups on aldehyde-modified natural polysaccharides via dynamic Schiff base reactions. These dynamic covalent bonds break under stress, resulting in a sol state that is fluid and exhibits shear thinning; when the stress is removed, these dynamic covalent bonds can be instantaneously rebuilt, resulting in a gel state that is non-fluid.
[0086] Example 5
[0087] An acute perforation was created in the tympanic membrane of a rat. The diameter of the acute perforation was approximately 1.2 mm. Samples from Example 1, Comparative Example 2, and Comparative Example 3 were injected into the perforation site, and the healing of the tympanic membrane was observed after 21 days.
[0088] Example 1: The tympanic membrane notch is intact and transparent (see Example 1). Figure 5 In contrast, in examples 1 and 2, the tympanic membrane was basically closed, but it was opaque and still showed some inflammation.
[0089] Therefore, the natural polysaccharide hydrogel loaded with platelet-rich plasma of this application has a good effect on promoting tympanic membrane healing; and compared with hydrogels using only natural polysaccharides (Comparative Example 2) or only platelet-rich plasma (Comparative Example 3), the natural polysaccharide hydrogel loaded with platelet-rich plasma of this application has a better effect on promoting tympanic membrane healing, and the two have a synergistic effect.
[0090] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and are not intended to limit it. Although the present invention has been described in detail with reference to preferred embodiments, those skilled in the art should understand that modifications or equivalent substitutions can be made to the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, and all such modifications or substitutions should be covered within the scope of the present invention.
Claims
1. A natural polysaccharide hydrogel loaded with platelet rich plasma, characterized in that: include, Chitosan derivatives, aldehyde-modified natural polysaccharides, and platelet-rich plasma; The hydrogel network is a dynamic cross-linked network, comprising a Schiff base-based dynamic cross-linked network formed by the amino and aldehyde-modified carboxyl groups of chitosan derivatives and platelet-rich plasma.
2. The natural polysaccharide hydrogel of claim 1, wherein: The chitosan derivative is one or more of carboxymethyl chitosan and quaternary ammonium salt chitosan; The aldehyde-modified natural polysaccharide is one or more of aldehyde-modified hyaluronic acid and aldehyde-modified chondroitin sulfate.
3. The method for preparing the natural polysaccharide hydrogel according to claim 1 or 2, characterized in that: include, A mixture containing chitosan derivatives, aldehyde-modified natural polysaccharides, and platelet-rich plasma was reacted at room temperature to obtain the platelet-loaded natural polysaccharide hydrogel.
4. The preparation method according to claim 3, characterized in that: This includes dissolving a chitosan derivative in platelet-rich plasma to obtain solution A; Prepare solution B containing aldehyde-modified natural polysaccharides; Solution A and solution B are mixed and reacted at room temperature to obtain the natural polysaccharide hydrogel loaded with platelet-rich plasma.
5. The preparation method according to claim 4, characterized in that: In solution A, the concentration of chitosan derivative is 3-5 wt%. In solution B, the concentration of aldehyde-modified natural polysaccharide is 2-6 wt%. The volume ratio of solution A to solution B is 1 to 16:
4.
6. The preparation method according to claim 4 or 5, characterized in that: The solvent used in solution B is an aqueous solution of sodium chloride; The concentration of the sodium chloride aqueous solution is 0.9–4 wt%.
7. The preparation method according to claim 6, characterized in that: The concentrations of the chitosan derivatives are 3 wt%, 3.5 wt%, 4 wt%, 4.5 wt%, and 5 wt%.
8. The preparation method according to claim 6, characterized in that: The concentrations of the aldehyde-modified natural polysaccharides are 2 wt%, 2.5 wt%, 3 wt%, 3.5 wt%, 4 wt%, 4.5 wt%, 5 wt%, 5.5 wt%, and 6 wt%.
9. The application of the natural polysaccharide hydrogel according to claim 1 or 2 as a tympanic membrane repair material.
